Login  |  Register

Live Stats

Partners

Actelion to discontinue setipiprant clinical development ...

Actelion to discontinue setipiprant clinical development in asthma & allergic rhinitis: Basel, Switzerland Monday, April 02, 2012, 17:10 Hrs [IST]

Alexa Traffic


Listing Links